Parameter
| Biomarker | sPD-L1 | Full name | Soluble Programmed Death-Ligand 1 | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prognosis |
| Disease | Bladder Cancer (BC) | Disease Subtypes | / | ||
| Organ | Bladder | Test Sample / Technology Platform | Serum & urine (ELISA) | ||
| Pathobiological Mechanisms | Detectable in serum; levels higher in muscle-invasive & metastatic BC; no prognostic value in urine | ||||
| Clinical Availability Status | Research verification stage | ||||
| Notes and Dynamics | Circulating immune-checkpoint marker; serum sPD-L1 prognostic value confirmed; needs clinical translation | ||||